Examination Report |
1 | TM-1 | 28 Dec 2010 |
2 | Reply to Exam Report (MIS-R) | 20 Apr 2013 |
3 | TM-5 | 07 Nov 2014 |
4 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 11 Jan 2018 |
5 | Letters related to TOP | 06 Jan 2020 |
6 | Letters related to TOP | 09 Jan 2020 |
7 | Annexure -1 under rule 46 | 11 Jan 2023 |
7 | Evidence Affidavit Under Rule 46 (TOP) | 11 Jan 2023 |
8 | Annexure -1 under rule 46 | 11 Jan 2023 |
8 | Evidence Affidavit Under Rule 46 (TOP) | 11 Jan 2023 |
1 | Hearing Notice (Show Cause) | 1474127 | 992870 | 01 Sep 2014 |
2 | Tribunal Accepted Notice for : 2076078 | 1571330 | 1025466 | 01 Oct 2014 |
3 | Hearing Notice | 14109576 | 5722521 | 20 Sep 2022 |
4 | Hearing Notice | 14510484 | 5802494 | 19 Dec 2022 |
The application for Alkamise was made on 28 December 2010.
The trademark applicant for Alkamise is TORRENT PHARMACEUTICALS.
Alkamise is applied in class(es) 5.
Application for Alkamise is on Opposed stage.
Application Id allotted to Alkamise is 2076078.
Alkamise filed with the Intellectual property office as a WORD.